“If you look at the risk to financial markets, I think inflation is for sure one, all driven by tariffs.”
Related Posts
These 9 biotech stocks have doubled this year and are set to double again, analysts say
The bio tech stocks have on average risen by 188% this year and have a median upside potential of 150%.
Barclays upgrades Boeing, sees a recovery for the airplane maker after a tough 2024
The firm upgraded the embattled plane maker’s stock to overweight.
Earnings playbook: Busiest week of the season includes reports from megacaps Apple and Amazon
More than 150 companies in the S&P 500 are slated to report.